Gamco Investors INC. ET AL Has $12.27 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Gamco Investors INC. ET AL trimmed its position in HCA Healthcare, Inc. (NYSE:HCA) by 10.5% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 28,784 shares of the company’s stock after selling 3,373 shares during the quarter. Gamco Investors INC. ET AL’s holdings in HCA Healthcare were worth $12,268,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of HCA. Norges Bank bought a new stake in shares of HCA Healthcare during the 2nd quarter valued at $1,152,408,000. Viking Global Investors LP grew its stake in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after purchasing an additional 690,773 shares during the period. Nordea Investment Management AB boosted its holdings in HCA Healthcare by 5.2% during the third quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock worth $415,656,000 after buying an additional 47,960 shares during the last quarter. Pacer Advisors Inc. increased its stake in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after acquiring an additional 896,437 shares during the last quarter. Finally, LSV Asset Management boosted its stake in HCA Healthcare by 0.4% during the 2nd quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after acquiring an additional 3,396 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling at HCA Healthcare

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total transaction of $903,528.78. Following the transaction, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the firm’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total transaction of $747,135.00. Following the completion of the transaction, the executive vice president directly owned 30,003 shares of the company’s stock, valued at $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 15,214 shares of company stock valued at $7,797,595. Corporate insiders own 1.30% of the company’s stock.

Analyst Ratings Changes

HCA has been the topic of several analyst reports. Royal Bank Of Canada increased their target price on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price objective on HCA Healthcare in a research note on Monday, February 9th. Robert W. Baird boosted their target price on HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Zacks Research cut HCA Healthcare from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 27th. Finally, Wall Street Zen downgraded shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $534.50.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst sentiment and research upgrades: several outlets and analysts continue to rate HCA favorably — one consensus snapshot called the stock a “Moderate Buy,” reflecting continued analyst confidence that HCA can grow earnings and return capital to shareholders. Article Title
• Positive Sentiment: Long-term demographic bull case: MarketBeat argues HCA is a likely beneficiary of U.S. aging demographics, noting management’s strong guidance (FY2026 EPS and EBITDA ranges), expanded capex, a $10B repurchase authorization and a raised dividend — all supportive of long‑term growth and shareholder returns. Article Title
• Neutral Sentiment: Analyst estimate tweaks from Zacks: Zacks Research nudged near‑term EPS estimates slightly higher for Q2, Q3 and Q4 2026 and raised FY2026 to $29.63, which supports the earnings outlook, but it kept a “Hold” rating — a modest positive but not a strong endorsement. Article Title
• Neutral Sentiment: Zacks’ view is mixed farther out: while FY2026 estimates were lifted, Zacks trimmed its FY2028 EPS forecast modestly — a sign analysts see near‑term strength but some uncertainty on longer‑term margin expansion. Article Title
• Neutral Sentiment: Local/industry headlines are mixed and mostly non‑company specific: a local hospital (Manchester’s Catholic Medical Center) plans to end outpatient mental‑health services and a leadership hire at Methodist Healthcare were reported — signals about regional capacity and staffing but with limited direct impact on HCA’s large national footprint. Article Title Article Title
• Negative Sentiment: Near‑term policy and revenue risks remain prominent: recent company commentary and market writeups note revenue growth was slightly below expectations in the prior quarter and management flagged $600–$900M of potential EBITDA headwinds from insurance‑exchange changes plus state supplemental payment declines — factors that could cap near‑term upside despite strong EPS. Article Title

HCA Healthcare Price Performance

HCA stock opened at $533.63 on Friday. The business has a 50-day moving average of $500.34 and a 200-day moving average of $465.40. HCA Healthcare, Inc. has a fifty-two week low of $310.18 and a fifty-two week high of $552.90. The stock has a market capitalization of $119.33 billion, a P/E ratio of 18.80, a P/E/G ratio of 1.64 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.During the same quarter in the previous year, the business posted $6.22 EPS. The business’s quarterly revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.6%. The ex-dividend date is Tuesday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.99%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.